Serveur d'exploration sur le cobalt au Maghreb

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines

Identifieur interne : 000280 ( PascalFrancis/Corpus ); précédent : 000279; suivant : 000281

Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines

Auteurs : I. H. Hall ; C. B. Lackey ; T. D. Kistler ; R. W. Jr Durham ; E. M. Jouad ; M. Khan ; X. D. Thanh ; S. Djebbar-Sid ; O. Benali-Baitich ; G. M. Bouet

Source :

RBID : Pascal:01-0086221

Descripteurs français

English descriptors

Abstract

The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S3 uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0031-7144
A02 01      @0 PHARAT
A03   1    @0 Pharmazie
A05       @2 55
A06       @2 12
A08 01  1  ENG  @1 Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines
A11 01  1    @1 HALL (I. H.)
A11 02  1    @1 LACKEY (C. B.)
A11 03  1    @1 KISTLER (T. D.)
A11 04  1    @1 DURHAM (R. W. JR)
A11 05  1    @1 JOUAD (E. M.)
A11 06  1    @1 KHAN (M.)
A11 07  1    @1 THANH (X. D.)
A11 08  1    @1 DJEBBAR-SID (S.)
A11 09  1    @1 BENALI-BAITICH (O.)
A11 10  1    @1 BOUET (G. M.)
A14 01      @1 Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina @2 Chapel Hill @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut.
A14 02      @1 Laboratoire de Chimie de Coordination , Faculte de Pharmacie @2 Angers @3 FRA @Z 5 aut. @Z 6 aut. @Z 7 aut. @Z 8 aut. @Z 10 aut.
A14 03      @1 Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie @2 Alger @3 DZA @Z 9 aut.
A20       @1 937-941
A21       @1 2000
A23 01      @0 ENG
A43 01      @1 INIST @2 3582 @5 354000093716840120
A44       @0 0000 @1 © 2001 INIST-CNRS. All rights reserved.
A45       @0 32 ref.
A47 01  1    @0 01-0086221
A60       @1 P
A61       @0 A
A64 01  1    @0 Pharmazie
A66 01      @0 DEU
C01 01    ENG  @0 The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S3 uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.
C02 01  X    @0 002B02R01
C03 01  X  FRE  @0 Activité biologique @5 01
C03 01  X  ENG  @0 Biological activity @5 01
C03 01  X  SPA  @0 Actividad biológica @5 01
C03 02  X  FRE  @0 Anticancéreux @5 02
C03 02  X  ENG  @0 Antineoplastic agent @5 02
C03 02  X  SPA  @0 Anticanceroso @5 02
C03 03  X  FRE  @0 Cytotoxicité @5 03
C03 03  X  ENG  @0 Cytotoxicity @5 03
C03 03  X  SPA  @0 Citotoxicidad @5 03
C03 04  X  FRE  @0 In vitro @5 04
C03 04  X  ENG  @0 In vitro @5 04
C03 04  X  SPA  @0 In vitro @5 04
C03 05  X  FRE  @0 Lignée cellulaire @5 05
C03 05  X  ENG  @0 Cell line @5 05
C03 05  X  SPA  @0 Línea celular @5 05
C03 06  X  FRE  @0 Cellule tumorale @5 06
C03 06  X  ENG  @0 Tumor cell @5 06
C03 06  X  SPA  @0 Célula tumoral @5 06
C03 07  X  FRE  @0 Homme @5 07
C03 07  X  ENG  @0 Human @5 07
C03 07  X  SPA  @0 Hombre @5 07
C03 08  X  FRE  @0 Animal @5 08
C03 08  X  ENG  @0 Animal @5 08
C03 08  X  SPA  @0 Animal @5 08
C03 09  X  FRE  @0 Souris @5 09
C03 09  X  ENG  @0 Mouse @5 09
C03 09  X  SPA  @0 Ratón @5 09
C03 10  X  FRE  @0 Lignée L1210 @5 10
C03 10  X  ENG  @0 L1210 cell line @5 10 @6 L«1210» cell line
C03 10  X  SPA  @0 Célula L1210 @5 10
C03 11  X  FRE  @0 Inhibition @5 11
C03 11  X  ENG  @0 Inhibition @5 11
C03 11  X  SPA  @0 Inhibición @5 11
C03 12  X  FRE  @0 Synthèse DNA @5 12
C03 12  X  ENG  @0 DNA synthesis @5 12
C03 12  X  SPA  @0 Síntesis ADN @5 12
C03 13  X  FRE  @0 Synthèse chimique @5 16
C03 13  X  ENG  @0 Chemical synthesis @5 16
C03 13  X  SPA  @0 Síntesis química @5 16
C03 14  X  FRE  @0 Cuivre Complexe @2 NC @2 NA @5 17
C03 14  X  ENG  @0 Copper Complexes @2 NC @2 NA @5 17
C03 14  X  SPA  @0 Cobre Complejo @2 NC @2 NA @5 17
C03 15  X  FRE  @0 Cobalt Complexe @2 NC @2 NA @5 18
C03 15  X  ENG  @0 Cobalt Complexes @2 NC @2 NA @5 18
C03 15  X  SPA  @0 Cobalto Complejo @2 NC @2 NA @5 18
C03 16  X  FRE  @0 Complexe chloro @5 20
C03 16  X  ENG  @0 Chloro complex @5 20
C03 16  X  SPA  @0 Complejo cloro @5 20
C03 17  X  FRE  @0 Complexe bromo @5 21
C03 17  X  ENG  @0 Bromo complex @5 21
C03 17  X  SPA  @0 Complejo bromo @5 21
C03 18  X  FRE  @0 Complexe aqua @5 22
C03 18  X  ENG  @0 Aqua complex @5 22
C03 18  X  SPA  @0 Complejo aqua @5 22
C03 19  X  FRE  @0 Coordinat organique @5 24
C03 19  X  ENG  @0 Organic ligand @5 24
C03 19  X  SPA  @0 Ligando orgánico @5 24
C03 20  X  FRE  @0 Semicarbazone @5 25
C03 20  X  ENG  @0 Semicarbazones @5 25
C03 20  X  SPA  @0 Semicarbazona @5 25
C03 21  X  FRE  @0 Thiosemicarbazone @5 26
C03 21  X  ENG  @0 Thiosemicarbazone @5 26
C03 21  X  SPA  @0 Tiosemicarbazona @5 26
C03 22  X  FRE  @0 Hétérocycle oxygène @5 27
C03 22  X  ENG  @0 Oxygen heterocycle @5 27
C03 22  X  SPA  @0 Heterociclo oxígeno @5 27
C03 23  X  FRE  @0 Cycle 5 chaînons @5 28
C03 23  X  ENG  @0 Five membered ring @5 28
C03 23  X  SPA  @0 Ciclo 5 eslabones @5 28
C03 24  X  FRE  @0 Furane dérivé @5 29
C03 24  X  ENG  @0 Furan derivatives @5 29
C03 24  X  SPA  @0 Furano derivado @5 29
C03 25  X  FRE  @0 Furfural(5-méthyl) semicarbazone @2 NK @2 FC @4 INC @5 62
C03 26  X  FRE  @0 Furfural thiosemicarbazone @2 NK @2 FC @4 INC @5 63
C07 01  X  FRE  @0 Rodentia @2 NS
C07 01  X  ENG  @0 Rodentia @2 NS
C07 01  X  SPA  @0 Rodentia @2 NS
C07 02  X  FRE  @0 Mammalia @2 NS
C07 02  X  ENG  @0 Mammalia @2 NS
C07 02  X  SPA  @0 Mammalia @2 NS
C07 03  X  FRE  @0 Vertebrata @2 NS
C07 03  X  ENG  @0 Vertebrata @2 NS
C07 03  X  SPA  @0 Vertebrata @2 NS
C07 04  X  FRE  @0 Métal transition Complexe @2 NC @2 NA @5 19
C07 04  X  ENG  @0 Transition metal Complexes @2 NC @2 NA @5 19
C07 04  X  SPA  @0 Metal transición Complejo @2 NC @2 NA @5 19
N21       @1 063

Format Inist (serveur)

NO : PASCAL 01-0086221 INIST
ET : Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines
AU : HALL (I. H.); LACKEY (C. B.); KISTLER (T. D.); DURHAM (R. W. JR); JOUAD (E. M.); KHAN (M.); THANH (X. D.); DJEBBAR-SID (S.); BENALI-BAITICH (O.); BOUET (G. M.)
AF : Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina/Chapel Hill/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut.); Laboratoire de Chimie de Coordination , Faculte de Pharmacie/Angers/France (5 aut., 6 aut., 7 aut., 8 aut., 10 aut.); Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie/Alger/Algérie (9 aut.)
DT : Publication en série; Niveau analytique
SO : Pharmazie; ISSN 0031-7144; Coden PHARAT; Allemagne; Da. 2000; Vol. 55; No. 12; Pp. 937-941; Bibl. 32 ref.
LA : Anglais
EA : The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S3 uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.
CC : 002B02R01
FD : Activité biologique; Anticancéreux; Cytotoxicité; In vitro; Lignée cellulaire; Cellule tumorale; Homme; Animal; Souris; Lignée L1210; Inhibition; Synthèse DNA; Synthèse chimique; Cuivre Complexe; Cobalt Complexe; Complexe chloro; Complexe bromo; Complexe aqua; Coordinat organique; Semicarbazone; Thiosemicarbazone; Hétérocycle oxygène; Cycle 5 chaînons; Furane dérivé; Furfural(5-méthyl) semicarbazone; Furfural thiosemicarbazone
FG : Rodentia; Mammalia; Vertebrata; Métal transition Complexe
ED : Biological activity; Antineoplastic agent; Cytotoxicity; In vitro; Cell line; Tumor cell; Human; Animal; Mouse; L1210 cell line; Inhibition; DNA synthesis; Chemical synthesis; Copper Complexes; Cobalt Complexes; Chloro complex; Bromo complex; Aqua complex; Organic ligand; Semicarbazones; Thiosemicarbazone; Oxygen heterocycle; Five membered ring; Furan derivatives
EG : Rodentia; Mammalia; Vertebrata; Transition metal Complexes
SD : Actividad biológica; Anticanceroso; Citotoxicidad; In vitro; Línea celular; Célula tumoral; Hombre; Animal; Ratón; Célula L1210; Inhibición; Síntesis ADN; Síntesis química; Cobre Complejo; Cobalto Complejo; Complejo cloro; Complejo bromo; Complejo aqua; Ligando orgánico; Semicarbazona; Tiosemicarbazona; Heterociclo oxígeno; Ciclo 5 eslabones; Furano derivado
LO : INIST-3582.354000093716840120
ID : 01-0086221

Links to Exploration step

Pascal:01-0086221

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines</title>
<author>
<name sortKey="Hall, I H" sort="Hall, I H" uniqKey="Hall I" first="I. H." last="Hall">I. H. Hall</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lackey, C B" sort="Lackey, C B" uniqKey="Lackey C" first="C. B." last="Lackey">C. B. Lackey</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kistler, T D" sort="Kistler, T D" uniqKey="Kistler T" first="T. D." last="Kistler">T. D. Kistler</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Durham, R W Jr" sort="Durham, R W Jr" uniqKey="Durham R" first="R. W. Jr" last="Durham">R. W. Jr Durham</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jouad, E M" sort="Jouad, E M" uniqKey="Jouad E" first="E. M." last="Jouad">E. M. Jouad</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Khan, M" sort="Khan, M" uniqKey="Khan M" first="M." last="Khan">M. Khan</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thanh, X D" sort="Thanh, X D" uniqKey="Thanh X" first="X. D." last="Thanh">X. D. Thanh</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Djebbar Sid, S" sort="Djebbar Sid, S" uniqKey="Djebbar Sid S" first="S." last="Djebbar-Sid">S. Djebbar-Sid</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Benali Baitich, O" sort="Benali Baitich, O" uniqKey="Benali Baitich O" first="O." last="Benali-Baitich">O. Benali-Baitich</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie</s1>
<s2>Alger</s2>
<s3>DZA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bouet, G M" sort="Bouet, G M" uniqKey="Bouet G" first="G. M." last="Bouet">G. M. Bouet</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">01-0086221</idno>
<date when="2000">2000</date>
<idno type="stanalyst">PASCAL 01-0086221 INIST</idno>
<idno type="RBID">Pascal:01-0086221</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000280</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines</title>
<author>
<name sortKey="Hall, I H" sort="Hall, I H" uniqKey="Hall I" first="I. H." last="Hall">I. H. Hall</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lackey, C B" sort="Lackey, C B" uniqKey="Lackey C" first="C. B." last="Lackey">C. B. Lackey</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Kistler, T D" sort="Kistler, T D" uniqKey="Kistler T" first="T. D." last="Kistler">T. D. Kistler</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Durham, R W Jr" sort="Durham, R W Jr" uniqKey="Durham R" first="R. W. Jr" last="Durham">R. W. Jr Durham</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Jouad, E M" sort="Jouad, E M" uniqKey="Jouad E" first="E. M." last="Jouad">E. M. Jouad</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Khan, M" sort="Khan, M" uniqKey="Khan M" first="M." last="Khan">M. Khan</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Thanh, X D" sort="Thanh, X D" uniqKey="Thanh X" first="X. D." last="Thanh">X. D. Thanh</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Djebbar Sid, S" sort="Djebbar Sid, S" uniqKey="Djebbar Sid S" first="S." last="Djebbar-Sid">S. Djebbar-Sid</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Benali Baitich, O" sort="Benali Baitich, O" uniqKey="Benali Baitich O" first="O." last="Benali-Baitich">O. Benali-Baitich</name>
<affiliation>
<inist:fA14 i1="03">
<s1>Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie</s1>
<s2>Alger</s2>
<s3>DZA</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Bouet, G M" sort="Bouet, G M" uniqKey="Bouet G" first="G. M." last="Bouet">G. M. Bouet</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Pharmazie</title>
<title level="j" type="abbreviated">Pharmazie</title>
<idno type="ISSN">0031-7144</idno>
<imprint>
<date when="2000">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Pharmazie</title>
<title level="j" type="abbreviated">Pharmazie</title>
<idno type="ISSN">0031-7144</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animal</term>
<term>Antineoplastic agent</term>
<term>Aqua complex</term>
<term>Biological activity</term>
<term>Bromo complex</term>
<term>Cell line</term>
<term>Chemical synthesis</term>
<term>Chloro complex</term>
<term>Cobalt Complexes</term>
<term>Copper Complexes</term>
<term>Cytotoxicity</term>
<term>DNA synthesis</term>
<term>Five membered ring</term>
<term>Furan derivatives</term>
<term>Human</term>
<term>In vitro</term>
<term>Inhibition</term>
<term>L1210 cell line</term>
<term>Mouse</term>
<term>Organic ligand</term>
<term>Oxygen heterocycle</term>
<term>Semicarbazones</term>
<term>Thiosemicarbazone</term>
<term>Tumor cell</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Activité biologique</term>
<term>Anticancéreux</term>
<term>Cytotoxicité</term>
<term>In vitro</term>
<term>Lignée cellulaire</term>
<term>Cellule tumorale</term>
<term>Homme</term>
<term>Animal</term>
<term>Souris</term>
<term>Lignée L1210</term>
<term>Inhibition</term>
<term>Synthèse DNA</term>
<term>Synthèse chimique</term>
<term>Cuivre Complexe</term>
<term>Cobalt Complexe</term>
<term>Complexe chloro</term>
<term>Complexe bromo</term>
<term>Complexe aqua</term>
<term>Coordinat organique</term>
<term>Semicarbazone</term>
<term>Thiosemicarbazone</term>
<term>Hétérocycle oxygène</term>
<term>Cycle 5 chaînons</term>
<term>Furane dérivé</term>
<term>Furfural(5-méthyl) semicarbazone</term>
<term>Furfural thiosemicarbazone</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S
<sup>3</sup>
uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0031-7144</s0>
</fA01>
<fA02 i1="01">
<s0>PHARAT</s0>
</fA02>
<fA03 i2="1">
<s0>Pharmazie</s0>
</fA03>
<fA05>
<s2>55</s2>
</fA05>
<fA06>
<s2>12</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>HALL (I. H.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LACKEY (C. B.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>KISTLER (T. D.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DURHAM (R. W. JR)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>JOUAD (E. M.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>KHAN (M.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>THANH (X. D.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>DJEBBAR-SID (S.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>BENALI-BAITICH (O.)</s1>
</fA11>
<fA11 i1="10" i2="1">
<s1>BOUET (G. M.)</s1>
</fA11>
<fA14 i1="01">
<s1>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina</s1>
<s2>Chapel Hill</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Laboratoire de Chimie de Coordination , Faculte de Pharmacie</s1>
<s2>Angers</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
<sZ>6 aut.</sZ>
<sZ>7 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>10 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie</s1>
<s2>Alger</s2>
<s3>DZA</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA20>
<s1>937-941</s1>
</fA20>
<fA21>
<s1>2000</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>3582</s2>
<s5>354000093716840120</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2001 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>32 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>01-0086221</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Pharmazie</s0>
</fA64>
<fA66 i1="01">
<s0>DEU</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S
<sup>3</sup>
uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02R01</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Activité biologique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Biological activity</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Actividad biológica</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Anticancéreux</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Antineoplastic agent</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Anticanceroso</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Cytotoxicité</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Cytotoxicity</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Citotoxicidad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>In vitro</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>In vitro</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>In vitro</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Lignée cellulaire</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Cell line</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Línea celular</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Cellule tumorale</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Tumor cell</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Célula tumoral</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Homme</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Human</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Animal</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Animal</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Animal</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Souris</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Mouse</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Ratón</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Lignée L1210</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>L1210 cell line</s0>
<s5>10</s5>
<s6>L«1210» cell line</s6>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Célula L1210</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Inhibition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Inhibition</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Inhibición</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Synthèse DNA</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>DNA synthesis</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Síntesis ADN</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Synthèse chimique</s0>
<s5>16</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>Chemical synthesis</s0>
<s5>16</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>Síntesis química</s0>
<s5>16</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Cuivre Complexe</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Copper Complexes</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>17</s5>
</fC03>
<fC03 i1="14" i2="X" l="SPA">
<s0>Cobre Complejo</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>17</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Cobalt Complexe</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="ENG">
<s0>Cobalt Complexes</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>18</s5>
</fC03>
<fC03 i1="15" i2="X" l="SPA">
<s0>Cobalto Complejo</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>18</s5>
</fC03>
<fC03 i1="16" i2="X" l="FRE">
<s0>Complexe chloro</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="ENG">
<s0>Chloro complex</s0>
<s5>20</s5>
</fC03>
<fC03 i1="16" i2="X" l="SPA">
<s0>Complejo cloro</s0>
<s5>20</s5>
</fC03>
<fC03 i1="17" i2="X" l="FRE">
<s0>Complexe bromo</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="ENG">
<s0>Bromo complex</s0>
<s5>21</s5>
</fC03>
<fC03 i1="17" i2="X" l="SPA">
<s0>Complejo bromo</s0>
<s5>21</s5>
</fC03>
<fC03 i1="18" i2="X" l="FRE">
<s0>Complexe aqua</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="ENG">
<s0>Aqua complex</s0>
<s5>22</s5>
</fC03>
<fC03 i1="18" i2="X" l="SPA">
<s0>Complejo aqua</s0>
<s5>22</s5>
</fC03>
<fC03 i1="19" i2="X" l="FRE">
<s0>Coordinat organique</s0>
<s5>24</s5>
</fC03>
<fC03 i1="19" i2="X" l="ENG">
<s0>Organic ligand</s0>
<s5>24</s5>
</fC03>
<fC03 i1="19" i2="X" l="SPA">
<s0>Ligando orgánico</s0>
<s5>24</s5>
</fC03>
<fC03 i1="20" i2="X" l="FRE">
<s0>Semicarbazone</s0>
<s5>25</s5>
</fC03>
<fC03 i1="20" i2="X" l="ENG">
<s0>Semicarbazones</s0>
<s5>25</s5>
</fC03>
<fC03 i1="20" i2="X" l="SPA">
<s0>Semicarbazona</s0>
<s5>25</s5>
</fC03>
<fC03 i1="21" i2="X" l="FRE">
<s0>Thiosemicarbazone</s0>
<s5>26</s5>
</fC03>
<fC03 i1="21" i2="X" l="ENG">
<s0>Thiosemicarbazone</s0>
<s5>26</s5>
</fC03>
<fC03 i1="21" i2="X" l="SPA">
<s0>Tiosemicarbazona</s0>
<s5>26</s5>
</fC03>
<fC03 i1="22" i2="X" l="FRE">
<s0>Hétérocycle oxygène</s0>
<s5>27</s5>
</fC03>
<fC03 i1="22" i2="X" l="ENG">
<s0>Oxygen heterocycle</s0>
<s5>27</s5>
</fC03>
<fC03 i1="22" i2="X" l="SPA">
<s0>Heterociclo oxígeno</s0>
<s5>27</s5>
</fC03>
<fC03 i1="23" i2="X" l="FRE">
<s0>Cycle 5 chaînons</s0>
<s5>28</s5>
</fC03>
<fC03 i1="23" i2="X" l="ENG">
<s0>Five membered ring</s0>
<s5>28</s5>
</fC03>
<fC03 i1="23" i2="X" l="SPA">
<s0>Ciclo 5 eslabones</s0>
<s5>28</s5>
</fC03>
<fC03 i1="24" i2="X" l="FRE">
<s0>Furane dérivé</s0>
<s5>29</s5>
</fC03>
<fC03 i1="24" i2="X" l="ENG">
<s0>Furan derivatives</s0>
<s5>29</s5>
</fC03>
<fC03 i1="24" i2="X" l="SPA">
<s0>Furano derivado</s0>
<s5>29</s5>
</fC03>
<fC03 i1="25" i2="X" l="FRE">
<s0>Furfural(5-méthyl) semicarbazone</s0>
<s2>NK</s2>
<s2>FC</s2>
<s4>INC</s4>
<s5>62</s5>
</fC03>
<fC03 i1="26" i2="X" l="FRE">
<s0>Furfural thiosemicarbazone</s0>
<s2>NK</s2>
<s2>FC</s2>
<s4>INC</s4>
<s5>63</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Rodentia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Mammalia</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Vertebrata</s0>
<s2>NS</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Métal transition Complexe</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>19</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Transition metal Complexes</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>19</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Metal transición Complejo</s0>
<s2>NC</s2>
<s2>NA</s2>
<s5>19</s5>
</fC07>
<fN21>
<s1>063</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 01-0086221 INIST</NO>
<ET>Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines</ET>
<AU>HALL (I. H.); LACKEY (C. B.); KISTLER (T. D.); DURHAM (R. W. JR); JOUAD (E. M.); KHAN (M.); THANH (X. D.); DJEBBAR-SID (S.); BENALI-BAITICH (O.); BOUET (G. M.)</AU>
<AF>Division of Medicinal Chemistry & Natural Products, School of Pharmacy, University of North Carolina/Chapel Hill/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut.); Laboratoire de Chimie de Coordination , Faculte de Pharmacie/Angers/France (5 aut., 6 aut., 7 aut., 8 aut., 10 aut.); Laboratoire de Chimie de Coordination, USTHB, Institut de Chimie/Alger/Algérie (9 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Pharmazie; ISSN 0031-7144; Coden PHARAT; Allemagne; Da. 2000; Vol. 55; No. 12; Pp. 937-941; Bibl. 32 ref.</SO>
<LA>Anglais</LA>
<EA>The 2-furfural semicarbazone and thiosemicarbazone copper and cobalt complexes demonstrated potent cytotoxicity against the growth of suspended leukemias and lymphomas as well as human lung MB9812, colon SW480, ovary 1-A9 and HeLa-S
<sup>3</sup>
uterine carcinoma. In L1210 lymphoid leukemia cell the complexes inhibited preferentially DNA synthesis over 60 min at 25 to 100 μM. The copper and cobalt complexes functioned by multiple mechanisms to suppress synthetic steps in nucleic acid metabolism to reduce deoxynucleotide pools for incorporation into DNA. At high concentrations the complexes suppressed human DNA topoisomerase II activity with DNA nicks and DNA fragmentation but they did not alkylate the bases of DNA, cause intercalation between base pairs or cause cross-linking of DNA strands.</EA>
<CC>002B02R01</CC>
<FD>Activité biologique; Anticancéreux; Cytotoxicité; In vitro; Lignée cellulaire; Cellule tumorale; Homme; Animal; Souris; Lignée L1210; Inhibition; Synthèse DNA; Synthèse chimique; Cuivre Complexe; Cobalt Complexe; Complexe chloro; Complexe bromo; Complexe aqua; Coordinat organique; Semicarbazone; Thiosemicarbazone; Hétérocycle oxygène; Cycle 5 chaînons; Furane dérivé; Furfural(5-méthyl) semicarbazone; Furfural thiosemicarbazone</FD>
<FG>Rodentia; Mammalia; Vertebrata; Métal transition Complexe</FG>
<ED>Biological activity; Antineoplastic agent; Cytotoxicity; In vitro; Cell line; Tumor cell; Human; Animal; Mouse; L1210 cell line; Inhibition; DNA synthesis; Chemical synthesis; Copper Complexes; Cobalt Complexes; Chloro complex; Bromo complex; Aqua complex; Organic ligand; Semicarbazones; Thiosemicarbazone; Oxygen heterocycle; Five membered ring; Furan derivatives</ED>
<EG>Rodentia; Mammalia; Vertebrata; Transition metal Complexes</EG>
<SD>Actividad biológica; Anticanceroso; Citotoxicidad; In vitro; Línea celular; Célula tumoral; Hombre; Animal; Ratón; Célula L1210; Inhibición; Síntesis ADN; Síntesis química; Cobre Complejo; Cobalto Complejo; Complejo cloro; Complejo bromo; Complejo aqua; Ligando orgánico; Semicarbazona; Tiosemicarbazona; Heterociclo oxígeno; Ciclo 5 eslabones; Furano derivado</SD>
<LO>INIST-3582.354000093716840120</LO>
<ID>01-0086221</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000280 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000280 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:01-0086221
   |texte=   Cytotoxicity of copper and cobalt complexes of furfural semicarbazone and thiosemicarbazone derivatives in murine and human tumor cell lines
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024